Read more https://www.businesswire.com/news/home/20210301005266/en/FogPharma%C2%AE-Announces-107-Million-Series-C-Financing-to-Advance-Direct-%CE%B2-Catenin-Antagonist-and-Universal-Druggability%E2%84%A2-Platform